Search

everythinglearnresearchcommunity

for

Search:↓

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

A genetic mutation in the LIPH gene causes a rare hair disorder with sparse, curly hair.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Topical diphencyprone effectively treated a 9-year-old boy's alopecia areata with fewer side effects.

Hair follicle development involves specific cells and genes, crucial for understanding severe skin diseases like harlequin ichthyosis.

AI improves aesthetic medicine but faces challenges like biases and privacy issues that need addressing for successful integration.

Hair diameter diversity helps assess hair loss, but its standard measure varies by individual and ethnicity.

Baricitinib effectively regrows scalp hair in most people with severe alopecia areata.

The supplement aims to improve care for children with alopecia areata.

Genetic discoveries are leading to new treatments for alopecia areata.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Improving blood vessel health and controlling uric acid may help manage alopecia areata.

ILC1-like cells may contribute to hair loss in alopecia areata.

Leflunomide and anthralin may effectively treat severe alopecia areata.

A 31-year-old man's hair turned white suddenly, likely due to alopecia areata.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Biotin supplements may help hair regrowth in alopecia areata patients with low biotinidase activity.

The study found certain scalp biopsy features can help tell apart alopecia areata from pattern hair loss even when typical immune cells are not seen.

There is no cure for alopecia areata, and treatment success depends on the individual's situation.

Alopecia areata causes significant emotional and social challenges, especially with more hair loss.

AHR ligands could treat inflammatory skin diseases.

Psychological factors significantly impact alopecia areata.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Alopecia areata doesn't significantly change the risk of common infections.

Access to JAK inhibitors for alopecia areata should be improved in the Military Healthcare System.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.